Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale
NCT ID: NCT01216423
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
374 participants
OBSERVATIONAL
2009-11-30
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Sleep Apnea Syndrome and Patent Foramen Ovale Among Victims of Cryptogenic Ischemic Stroke
NCT04846205
Assessment of Early Vascular Damage With Advanced Neuroimaging in Patient With Patent Foramen Ovale
NCT04549272
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
NCT02893631
Prediction of Patient-specific Outcomes After Interventional neuroRadiology Procedures
NCT04504695
Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen Ovale
NCT01149447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* age \> 18 years old
* confirmed pulmonary embolism
* informed consent
* social ensured
Exclusion criteria :
* pregnancy
* age \< 18 years old
* protected major person (in sense of public health)
* consent refused
* MRI contraindications
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Incidence of recent stroke in patients with PFO
No interventions assigned to this group
Incidence of recent stroke in patients without PFO
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed pulmonary embolism
* informed consent
* social ensured
Exclusion Criteria
* age \< 18 years old
* protected major person (in sense of public health)
* consent refused
* MRI contraindications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuelle LE MOIGNE, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Army Hospital
Brest, France, France
CHU Dijon de Bocage
Dijon, France, France
Centre Hospitalier de Cornouaille
Quimper, France, France
Brest University Hospital
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Le Moigne E, Timsit S, Ben Salem D, Didier R, Jobic Y, Paleiron N, Le Mao R, Joseph T, Hoffmann C, Dion A, Rousset J, Le Gal G, Lacut K, Leroyer C, Mottier D, Couturaud F. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism: A Prospective Cohort Study. Ann Intern Med. 2019 Jun 4;170(11):756-763. doi: 10.7326/M18-3485. Epub 2019 May 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPIC-FOP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.